Medicine Description Epikavit 10 mg
Epikavit ampoules are a medication containing the active ingredient phytomenadione at a concentration of 10 mg in each ampoule. Phytomenadione, also known as vitamin K1, is an essential vitamin that plays an important role in blood clotting. This medication is used to treat bleeding or life-threatening bleeding caused by low blood levels of prothrombin (factor II) or factor VII. It is also used to antagonize the effect of coumarin-type anticoagulants such as warfarin.
What are the ingredients in Epikavit?
Epikavit ampoules contain the following active ingredient:
Phytomenadione: 10 mg per ampoule.
Phytomenadione is usually available as an injection solution. The solution may also contain inactive ingredients to help stabilize the medication and make it suitable for injection. No other strengths or forms of this product are available, according to available information.
Indications for Use of Epikavit
Epikavit ampoules are used in the following cases:
Treatment of bleeding or the risk of severe bleeding resulting from vitamin K deficiency due to malabsorption, nutritional deficiencies, or the use of certain medications.
Treatment of bleeding resulting from an overdose of coumarin-type anticoagulants, such as warfarin.
Treatment or prevention of bleeding in newborns with vitamin K deficiency hemorrhagic disease of the newborn.
Treatment of other rare blood clotting disorders associated with vitamin K deficiency.
This medication should be used under close medical supervision and in hospitals or medical centers equipped to handle severe bleeding.
What are the dosages of Epikavit?
The dosage and method of administration are determined by a specialist physician based on the cause and severity of the bleeding, the patient's condition, and their response to treatment.
Epikavit is given by slow intravenous injection or intramuscular injection. Intravenous injection is preferred in cases of severe or life-threatening bleeding.
The dosage depends on the patient's age, weight, and coagulation status. Blood clotting tests are monitored regularly to assess the patient's response to treatment and adjust the dosage if necessary.
In cases of warfarin overdose, the dosage depends on the INR (International Normalized Ratio) value and the speed at which warfarin reversal is needed.